{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:08:05Z","timestamp":1793218085827,"version":"4.5.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/I\/20\/2\/505181"],"award-info":[{"award-number":["IA\/I\/20\/2\/505181"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>\n                    Pathways of intrinsic resistance in bacteria are promising targets for novel antibiotics and resistance breakers. Here, we used a genome-wide screen to identify single gene knockouts of\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    that were hypersusceptible to trimethoprim and chloramphenicol, two chemically diverse broad-spectrum antibiotics. Among the hits from our screen, knockouts of\n                    <jats:italic>acrB<\/jats:italic>\n                    , an efflux pump, and\n                    <jats:italic>rfaG<\/jats:italic>\n                    or\n                    <jats:italic>lpxM<\/jats:italic>\n                    , both involved in cell envelope biogenesis, were hypersensitive to multiple antimicrobials and could sensitize genetically resistant\n                    <jats:italic>E. coli<\/jats:italic>\n                    strains to antibiotics. Using experimental evolution under trimethoprim pressure, we show that high drug selection regimes drove these knockouts to extinction more frequently than wild type. Among them, \u0394\n                    <jats:italic>acrB<\/jats:italic>\n                    was most compromised in its ability to evolve resistance, establishing it as a promising target for \u201cresistance proofing.\u201d At a sub-inhibitory trimethoprim concentration, however, all three knockouts adapted to the antibiotic and consequently recovered from hypersensitivity, albeit to different extents. This recovery was driven by mutations in drug-specific resistance pathways, rather than compensatory evolution, frequently involving upregulation of the drug target. Notably, resistance-conferring mutations could by-pass defects in cell wall biosynthesis more effectively than efflux even though resistant mutations did not directly engage either pathway. Since inhibiting drug-efflux emerged as a better strategy, we tested the ability of chlorpromazine, an efflux pump inhibitor (EPI), to resistance proof\n                    <jats:italic>E. coli<\/jats:italic>\n                    against trimethoprim. While qualitatively similar in the short term, genetic and pharmacological inhibition differed dramatically on an evolutionary time scale due to evolution of resistance to the EPI. Further, adaptation to the EPI-antibiotic pair also led to multidrug adaptation. The lack of concordance between genetic and pharmacological inhibition revealed a crucial lacuna in our understanding of the mutational repertoires that facilitate adaptation to antibiotics in bacteria. We propose that while intrinsic resistance mechanisms are effective targets for antibiotic sensitization, rapid evolutionary recovery may significantly limit their utility.\n                  <\/jats:p>","DOI":"10.1371\/journal.pbio.3003443","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:33:54Z","timestamp":1761154434000},"page":"e3003443","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impeding pathways of intrinsic resistance in Escherichia coli confers antibiotic sensitization and resistance proofing"],"prefix":"10.1371","volume":"23","author":[{"given":"Manasvi","family":"Balachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaan","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmaya","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-3931","authenticated-orcid":true,"given":"Nishad","family":"Matange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"10459","key":"pbio.3003443.ref001","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet"},{"key":"pbio.3003443.ref002","volume-title":"Antimicrobial resistance research and surveillance network annual report","author":"ICfMR","year":"2021"},{"issue":"1","key":"pbio.3003443.ref003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/EBC20160063","article-title":"Intrinsic, adaptive and acquired antimicrobial resistance in Gram-negative bacteria","volume":"61","author":"M Arzanlou","year":"2017","journal-title":"Essays Biochem"},{"key":"pbio.3003443.ref004","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.mib.2023.102291","article-title":"Reservoirs of antimicrobial resistance in the context of One Health","volume":"73","author":"M Despotovic","year":"2023","journal-title":"Curr Opin Microbiol"},{"issue":"12","key":"pbio.3003443.ref005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"D Brown","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"pbio.3003443.ref006","doi-asserted-by":"crossref","first-page":"887251","DOI":"10.3389\/fmicb.2022.887251","article-title":"Antibiotic potentiators against multidrug-resistant bacteria: discovery, development, and clinical relevance","volume":"13","author":"M Chawla","year":"2022","journal-title":"Front Microbiol"},{"issue":"5","key":"pbio.3003443.ref007","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/femsre\/fuz014","article-title":"Antibiotic resistance breakers: current approaches and future directions","volume":"43","author":"M Laws","year":"2019","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"pbio.3003443.ref008","first-page":"415","article-title":"Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor","volume":"19","author":"BR Smith","year":"1985","journal-title":"Drug Intell Clin Pharm"},{"issue":"12","key":"pbio.3003443.ref009","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1021\/acsomega.3c00312","article-title":"Antibiotic adjuvants: a versatile approach to combat antibiotic resistance","volume":"8","author":"G Dhanda","year":"2023","journal-title":"ACS Omega"},{"issue":"9","key":"pbio.3003443.ref010","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/antibiotics9090623","article-title":"Overcoming intrinsic and acquired resistance mechanisms associated with the cell wall of Gram-negative bacteria","volume":"9","author":"RE Impey","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"pbio.3003443.ref011","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/antibiotics12091417","article-title":"Advances in the discovery of efflux pump inhibitors as novel potentiators to control antimicrobial-resistant pathogens","volume":"12","author":"S Zhang","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"pbio.3003443.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005629","article-title":"Genetic architecture of intrinsic antibiotic susceptibility","volume":"4","author":"HS Girgis","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"pbio.3003443.ref013","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.00906-09","article-title":"Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code","volume":"54","author":"A Liu","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pbio.3003443.ref014","article-title":"The intrinsic macrolide resistome of Escherichia coli","volume":"68","author":"Y Ma","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pbio.3003443.ref015","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1128\/AAC.00222-08","article-title":"Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility","volume":"52","author":"EBM Breidenstein","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pbio.3003443.ref016","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1128\/AAC.00507-08","article-title":"Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa","volume":"52","author":"KN Schurek","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"pbio.3003443.ref017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fmicb.2013.00103","article-title":"The intrinsic resistome of bacterial pathogens","volume":"4","author":"J Olivares","year":"2013","journal-title":"Front Microbiol"},{"issue":"1","key":"pbio.3003443.ref018","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab050","article-title":"Critical discussion on drug efflux in Mycobacterium tuberculosis","volume":"46","author":"S Remm","year":"2022","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"pbio.3003443.ref019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12866-025-03850-7","article-title":"Chlorpromazine inhibits the plasmid-mediated oqxAB multidrug efflux pump in Escherichia coli isolates of Egyptian patients with utis","volume":"25","author":"K Baraka","year":"2025","journal-title":"BMC Microbiol"},{"issue":"3","key":"pbio.3003443.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00465-20","article-title":"Chlorpromazine and amitriptyline are substrates and inhibitors of the AcrB multidrug efflux pump","volume":"11","author":"EM Grimsey","year":"2020","journal-title":"mBio"},{"issue":"1","key":"pbio.3003443.ref021","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1128\/AAC.04019-14","article-title":"Verapamil increases the bactericidal activity of bedaquiline against Mycobacterium tuberculosis in a mouse model","volume":"59","author":"S Gupta","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pbio.3003443.ref022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/antibiotics8020055","article-title":"Antimicrobial and synergistic effects of commercial piperine and piperlongumine in combination with conventional antimicrobials","volume":"8","author":"EE Mgbeahuruike","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"pbio.3003443.ref023","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijantimicag.2016.09.014","article-title":"Synergistic combinations of polymyxins","volume":"48","author":"JR Lenhard","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"pbio.3003443.ref024","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jac\/dkad394","article-title":"Synergy of polymyxin B and minocycline against KPC-3- and OXA-48-producing Klebsiella pneumoniae in dynamic time-kill experiments: agreement with in silico predictions","volume":"79","author":"A Olsson","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"pbio.3003443.ref025","doi-asserted-by":"crossref","first-page":"1390765","DOI":"10.3389\/fmicb.2024.1390765","article-title":"Synergistic action of antimicrobial peptides and antibiotics: current understanding and future directions","volume":"15","author":"S Taheri-Araghi","year":"2024","journal-title":"Front Microbiol"},{"issue":"9","key":"pbio.3003443.ref026","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/acsinfecdis.2c00193","article-title":"Synergy by perturbing the Gram-negative outer membrane: opening the door for Gram-positive specific antibiotics","volume":"8","author":"CMJ Wesseling","year":"2022","journal-title":"ACS Infect Dis"},{"issue":"1","key":"pbio.3003443.ref027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s44259-025-00096-1","article-title":"Antibiotics re-booted-time to kick back against drug resistance","volume":"3","author":"MAT Blaskovich","year":"2025","journal-title":"NPJ Antimicrob Resist"},{"key":"pbio.3003443.ref028","doi-asserted-by":"crossref","first-page":"100890","DOI":"10.1016\/j.drup.2022.100890","article-title":"Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat","volume":"66","author":"A Upadhayay","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"11","key":"pbio.3003443.ref029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002299","article-title":"Quantifying the determinants of evolutionary dynamics leading to drug resistance","volume":"13","author":"G Chevereau","year":"2015","journal-title":"PLoS Biol"},{"issue":"1","key":"pbio.3003443.ref030","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41467-020-16932-z","article-title":"Highly parallel lab evolution reveals that epistasis can curb the evolution of antibiotic resistance","volume":"11","author":"M Luka\u010di\u0161inov\u00e1","year":"2020","journal-title":"Nat Commun"},{"issue":"22","key":"pbio.3003443.ref031","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.10.024","article-title":"Efflux-linked accelerated evolution of antibiotic resistance at a population edge","volume":"82","author":"S Bhattacharyya","year":"2022","journal-title":"Mol Cell"},{"issue":"1","key":"pbio.3003443.ref032","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1038\/s41467-020-17735-y","article-title":"Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates","volume":"11","author":"A Papkou","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"pbio.3003443.ref033","article-title":"Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa","volume":"13","author":"X-Q Yu","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"8","key":"pbio.3003443.ref034","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acsinfecdis.3c00605","article-title":"Conserved evolutionary trajectory can be perturbed to prevent resistance evolution under norfloxacin pressure by forcing Mycobacterium smegmatis on alternate evolutionary paths","volume":"10","author":"Akanksha","year":"2024","journal-title":"ACS Infect Dis"},{"key":"pbio.3003443.ref035","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1038\/ncomms8385","article-title":"Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes","volume":"6","author":"AC Palmer","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"pbio.3003443.ref036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ng.1034","article-title":"Evolutionary paths to antibiotic resistance under dynamically sustained drug selection","volume":"44","author":"E Toprak","year":"2011","journal-title":"Nat Genet"},{"issue":"6304","key":"pbio.3003443.ref037","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aag0822","article-title":"Spatiotemporal microbial evolution on antibiotic landscapes","volume":"353","author":"M Baym","year":"2016","journal-title":"Science"},{"key":"pbio.3003443.ref038","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70931","article-title":"Adaptation and compensation in a bacterial gene regulatory network evolving under antibiotic selection","volume":"10","author":"V Patel","year":"2021","journal-title":"Elife"},{"issue":"6","key":"pbio.3003443.ref039","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02119-23","article-title":"Pervasive gene deregulation underlies adaptation and maladaptation in trimethoprim-resistant E. coli","volume":"14","author":"R Vinchhi","year":"2023","journal-title":"mBio"},{"key":"pbio.3003443.ref040","doi-asserted-by":"crossref","DOI":"10.1038\/msb4100050","article-title":"Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection","volume":"2","author":"T Baba","year":"2006","journal-title":"Mol Syst Biol"},{"key":"pbio.3003443.ref041","article-title":"The EcoCyc database (2025)","author":"PD Karp","year":"2025","journal-title":"EcoSal Plus"},{"key":"pbio.3003443.ref042","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.99785","article-title":"Proteostasis modulates gene dosage evolution in antibiotic-resistant bacteria","volume":"13","author":"C Jena","year":"2025","journal-title":"Elife"},{"issue":"2","key":"pbio.3003443.ref043","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01577-18","article-title":"The antibiotic trimethoprim displays strong mutagenic synergy with 2-aminopurine","volume":"63","author":"S D\u2019Souza","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"pbio.3003443.ref044","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0092-8674(95)90210-4","article-title":"Why is DsbA such an oxidizing disulfide catalyst?","volume":"83","author":"U Grauschopf","year":"1995","journal-title":"Cell"},{"issue":"2","key":"pbio.3003443.ref045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2443.1996.d01-233.x","article-title":"Roles of cysteine residues of DsbB in its activity to reoxidize DsbA, the protein disulphide bond catalyst of Escherichia coli","volume":"1","author":"S Kishigami","year":"1996","journal-title":"Genes Cells"},{"issue":"10","key":"pbio.3003443.ref046","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1128\/JB.00110-13","article-title":"DsbA and MgrB regulate steA expression through the two-component system PhoQ\/PhoP in Salmonella enterica","volume":"195","author":"E Cardenal-Mu\u00f1oz","year":"2013","journal-title":"J Bacteriol"},{"issue":"17","key":"pbio.3003443.ref047","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1128\/JB.183.17.5008-5014.2001","article-title":"Characterization of PitA and PitB from Escherichia coli","volume":"183","author":"RM Harris","year":"2001","journal-title":"J Bacteriol"},{"key":"pbio.3003443.ref048","doi-asserted-by":"crossref","first-page":"1178636119889629","DOI":"10.1177\/1178636119889629","article-title":"Identification of AcrAB-TolC efflux pump genes and detection of mutation in efflux repressor AcrR from omeprazole responsive multidrug-resistant Escherichia coli isolates causing urinary tract infections","volume":"12","author":"N Chowdhury","year":"2019","journal-title":"Microbiol Insights"},{"issue":"1","key":"pbio.3003443.ref049","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/s41467-022-30889-1","article-title":"Evolutionary action of mutations reveals antimicrobial resistance genes in Escherichia coli","volume":"13","author":"DC Marciano","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"pbio.3003443.ref050","doi-asserted-by":"crossref","first-page":"001304","DOI":"10.1099\/jmm.0.001304","article-title":"In vitro synergy of 5-nitrofurans, vancomycin and sodium deoxycholate against Gram-negative pathogens","volume":"70","author":"C Olivera","year":"2021","journal-title":"J Med Microbiol"},{"issue":"9","key":"pbio.3003443.ref051","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1021\/acsinfecdis.1c00318","article-title":"Vancomyxins: vancomycin-polymyxin nonapeptide conjugates that retain anti-Gram-positive activity with enhanced potency against Gram-negative strains","volume":"7","author":"E van Groesen","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"4","key":"pbio.3003443.ref052","doi-asserted-by":"crossref","first-page":"807","DOI":"10.15252\/msb.20156098","article-title":"Systematic discovery of drug interaction mechanisms","volume":"11","author":"G Chevereau","year":"2015","journal-title":"Mol Syst Biol"},{"issue":"7787","key":"pbio.3003443.ref053","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-019-1791-1","article-title":"A new antibiotic selectively kills Gram-negative pathogens","volume":"576","author":"Y Imai","year":"2019","journal-title":"Nature"},{"key":"pbio.3003443.ref054","doi-asserted-by":"crossref","first-page":"117440","DOI":"10.1016\/j.ejmech.2025.117440","article-title":"Research progress of LpxC inhibitor on Gram-negative bacteria","volume":"289","author":"H Wu","year":"2025","journal-title":"Eur J Med Chem"},{"issue":"1","key":"pbio.3003443.ref055","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/s41467-025-56934-3","article-title":"Exploring the principles behind antibiotics with limited resistance","volume":"16","author":"E Maharramov","year":"2025","journal-title":"Nat Commun"},{"issue":"6","key":"pbio.3003443.ref056","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5483\/BMBRep.2023-0070","article-title":"AcrAB-TolC, a major efflux pump in Gram negative bacteria: toward understanding its operation mechanism","volume":"56","author":"S Jang","year":"2023","journal-title":"BMB Rep"},{"issue":"3","key":"pbio.3003443.ref057","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jac\/dkab452","article-title":"Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants","volume":"77","author":"ML Ciusa","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pbio.3003443.ref058","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.45.4.1126-1136.2001","article-title":"Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes","volume":"45","author":"MC Sulavik","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pbio.3003443.ref059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050007","article-title":"Drug export pathway of multidrug exporter AcrB revealed by DARPin inhibitors","volume":"5","author":"G Sennhauser","year":"2007","journal-title":"PLoS Biol"},{"issue":"1","key":"pbio.3003443.ref060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41467-017-02493-1","article-title":"Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition","volume":"9","author":"M Zwama","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"pbio.3003443.ref061","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01056-20","article-title":"Mapping the role of AcrAB-TolC efflux pumps in the evolution of antibiotic resistance reveals near-MIC treatments facilitate resistance acquisition","volume":"5","author":"AM Langevin","year":"2020","journal-title":"mSphere"},{"issue":"5","key":"pbio.3003443.ref062","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1128\/AAC.45.5.1467-1472.2001","article-title":"Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone","volume":"45","author":"AS Jellen-Ritter","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"pbio.3003443.ref063","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/membranes12121264","article-title":"Understanding functional redundancy and promiscuity of multidrug transporters in E. coli under lipophilic cation stress","volume":"12","author":"MS Radi","year":"2022","journal-title":"Membranes (Basel)"},{"issue":"4","key":"pbio.3003443.ref064","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jac\/dkt481","article-title":"Redundancy in the periplasmic adaptor proteins AcrA and AcrE provides resilience and an ability to export substrates of multidrug efflux","volume":"69","author":"HE Smith","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pbio.3003443.ref065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1096\/fba.2020-00100","article-title":"Antivirulence DsbA inhibitors attenuate Salmonella enterica serovar Typhimurium fitness without detectable resistance","volume":"3","author":"R Dhouib","year":"2021","journal-title":"FASEB Bioadv"},{"issue":"4","key":"pbio.3003443.ref066","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/cb500988r","article-title":"Small molecule inhibitors of disulfide bond formation by the bacterial DsbA-DsbB dual enzyme system","volume":"10","author":"MA Halili","year":"2015","journal-title":"ACS Chem Biol"},{"key":"pbio.3003443.ref067","article-title":"Alternate genetic paths of adaptation to spectinomycin in Escherichia coli","author":"C Jena","year":"2025","journal-title":"Genetics"},{"issue":"7","key":"pbio.3003443.ref068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200272","article-title":"pH plays a role in the mode of action of trimethoprim on Escherichia coli","volume":"13","author":"H AlRabiah","year":"2018","journal-title":"PLoS One"},{"key":"pbio.3003443.ref069","doi-asserted-by":"crossref","first-page":"1093156","DOI":"10.3389\/frabi.2023.1093156","article-title":"Resistance-resistant antibacterial treatment strategies","volume":"2","author":"JI Batchelder","year":"2023","journal-title":"Front Antibiot"},{"issue":"12","key":"pbio.3003443.ref070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.tips.2014.10.007","article-title":"Resistance-resistant antibiotics","volume":"35","author":"E Oldfield","year":"2014","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"pbio.3003443.ref071","article-title":"Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review","volume":"4","author":"JS Mallick","year":"2022","journal-title":"JAC Antimicrob Resist"},{"issue":"20","key":"pbio.3003443.ref072","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1111\/febs.15370","article-title":"Targeting evolution to inhibit antibiotic resistance","volume":"287","author":"H Merrikh","year":"2020","journal-title":"FEBS J"},{"issue":"3","key":"pbio.3003443.ref073","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0007-2017","article-title":"Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp","volume":"6","author":"A Lupo","year":"2018","journal-title":"Microbiol Spectr"},{"issue":"4","key":"pbio.3003443.ref074","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01340-20","article-title":"New multidrug efflux inhibitors for Gram-negative bacteria","volume":"11","author":"RL Marshall","year":"2020","journal-title":"mBio"},{"issue":"9","key":"pbio.3003443.ref075","first-page":"1328","article-title":"Drug efflux pump inhibitors: a promising approach to counter multidrug resistance in Gram-negative pathogens by targeting AcrB protein from AcrAB-TolC multidrug efflux pump from Escherichia coli","volume":"11","author":"R Alenazy","year":"2022","journal-title":"Biology (Basel)"},{"issue":"1","key":"pbio.3003443.ref076","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3390\/antibiotics12010180","article-title":"Update on the discovery of efflux pump inhibitors against critical priority Gram-negative bacteria","volume":"12","author":"N Compagne","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"pbio.3003443.ref077","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/pharmaceutics16020170","article-title":"Bacterial efflux pump inhibitors reduce antibiotic resistance","volume":"16","author":"L Zhang","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"pbio.3003443.ref078","doi-asserted-by":"crossref","first-page":"102005","DOI":"10.1016\/j.xpro.2022.102005","article-title":"Adaptive laboratory evolution of antimicrobial resistance in bacteria for genetic and phenotypic analyses","volume":"4","author":"R Vinchhi","year":"2023","journal-title":"STAR Protoc"},{"issue":"2","key":"pbio.3003443.ref079","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.mimet.2008.06.010","article-title":"Antibiotic marker modifications of lambda Red and FLP helper plasmids, pKD46 and pCP20, for inactivation of chromosomal genes using PCR products in multidrug-resistant strains","volume":"75","author":"B Doublet","year":"2008","journal-title":"J Microbiol Methods"},{"issue":"1","key":"pbio.3003443.ref080","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1186\/1471-2164-15-1039","article-title":"Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq","volume":"15","author":"JE Barrick","year":"2014","journal-title":"BMC Genomics"},{"key":"pbio.3003443.ref081","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-4939-0554-6_12","article-title":"Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq","volume":"1151","author":"DE Deatherage","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"8","key":"pbio.3003443.ref082","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nmeth895","article-title":"A comprehensive library of fluorescent transcriptional reporters for Escherichia coli","volume":"3","author":"A Zaslaver","year":"2006","journal-title":"Nat Methods"},{"issue":"3","key":"pbio.3003443.ref083","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00561-19","article-title":"Highly contingent phenotypes of lon protease deficiency in Escherichia coli upon antibiotic challenge","volume":"202","author":"N Matange","year":"2020","journal-title":"J Bacteriol"},{"issue":"12","key":"pbio.3003443.ref084","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1042\/BCJ20180249","article-title":"Trade-offs with stability modulate innate and mutationally acquired drug resistance in bacterial dihydrofolate reductase enzymes","volume":"475","author":"N Matange","year":"2018","journal-title":"Biochem J"},{"issue":"1","key":"pbio.3003443.ref085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"FC Odds","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3003443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:34:05Z","timestamp":1761154445000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3003443"}},"subtitle":[],"editor":[{"given":"J. Arjan G. M.","family":"de Visser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":85,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3003443","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}